DFCM
SPPI

Dark Forest Capital Management’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Dark Forest Capital Management’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,320
Closed -$486 – 1618
2022
Q4 		$486 Buy
+1,320
New +$557 ﹤0.01% 1015

Other funds holding SPPI

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $195M AUM 51.17% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Dark Forest Capital Management's SPPI Position: Q1 2023 in Review

Dark Forest Capital Management sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q1 2023, closing a stake of 1,320 shares — an estimated $486 sold.

Dark Forest Capital Management first reported a position in SPPI in Q4 2022 and held it in 1 quarter. The position peaked at $486 in Q4 2022. 69 funds tracked by Wall St. Rank hold SPPI as of Q1 2023.

  • Dark Forest Capital Management reported no remaining Spectrum Pharmaceuticals Inc position as of Q1 2023 after selling out during the quarter.
  • Dark Forest Capital Management sold 1,320 Spectrum Pharmaceuticals Inc shares in Q1 2023, an estimated $486.
  • Dark Forest Capital Management first reported a position in Spectrum Pharmaceuticals Inc in Q4 2022 and held it in 1 quarter.
  • Dark Forest Capital Management's Spectrum Pharmaceuticals Inc position peaked at $486 in Q4 2022.
  • 69 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q1 2023.

Based on Dark Forest Capital Management's 13F filing for Q1 2023, filed 12 May 2023.